![{[setting('site_name')]}](https://www.projxnews.com/uploads/setting/16983847711140531930.webp)
Rx Propellant, a science and R&D infrastructure platform established by Actis and part of General Atlantic, has announced plans to invest $100 million in developing a large-format life sciences campus in Genome Valley, Hyderabad.
The investment was unveiled during the inaugural session of BioAsia 2026, the 23rd edition of the global life sciences and biotechnology forum held in the city.
Envisioned as a long-term commitment to advancing India’s life sciences ecosystem, the project will involve the phased development of over one million square feet of state-of-the-art laboratory infrastructure over the next six years.
Designed as a single integrated campus with multiple interconnected blocks, the facility is expected to become the largest life sciences campus in Genome Valley. It will cater to companies seeking high-quality, professionally managed laboratory and R&D spaces supported by resilient infrastructure and comprehensive services.
News by Rahul Yelligetti.
